SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

POET Technologies, Inc. engages in the designing, developing, manufacturing and sale of opto-electronic solutions for the sensing, data communications and telecommunications markets. It developed POET Optical Interposer platform, which allows the integration of electronic and photonic devices into a single multi-chip module. The company was founded on November 14, 1985 and is headquartered in Toronto, Canada.

POET Technologies Inc

POET Technologies is experiencing intense volatility and downward pressure after Marvell canceled its purchase orders, citing a confidentiality breach caused by the CFO's recent public commentary. Community members are deeply divided between long-term bulls who believe in the company's underlying photonics technology and frustrated investors who are calling for management accountability and questioning the firm's transparency after news of the cancellation was delayed.

Lucid Group, Inc. manufactures electric vehicles. It designs, develops, and builds energy storage systems for electric vehicles and supplies automakers with the battery pack system needed to power hybrid, plug-in, and electric vehicles. The company was founded in December 2007 and is headquartered in Newark, CA.

Lucid Group Inc

Lucid Group is trending as investors grapple with persistent downward pressure and concerns over potential dilution, despite the company's focus on its upcoming mid-size vehicle platform and continued financial backing from key institutional partners. Community sentiment remains sharply divided between long-term bulls highlighting the company's technical product advantages and skeptics who fear further share price erosion and the threat of bankruptcy or restructuring.

Erasca, Inc. is a clinical stage precision oncology company. It focuses on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. It has assembled a wholly owned or controlled RAS/MAPK pathway focused pipeline comprising modality-agnostic programs. The company was founded by Jonathan E. Lim and Kevan Shokat on July 2, 2018 and is headquartered in San Diego, CA.

Erasca Inc

Erasca Inc. is facing intense market scrutiny following an 8-K filing that disclosed a patient death in its Phase 1 oncology trial, fueling investor concerns over drug toxicity and trial management. While some retail traders are debating whether the price drop presents a buying opportunity, many community members are aggressively rotating into competitors like Revolution Medicines ($RVMD), citing superior safety profiles and clearer acquisition prospects.

Moolec Science SA engages in the development and production of science-based food ingredients. Its products include pet food, animal feed, and dietary supplements. It operates through the following segments: Seed and Integrated Products, Crop Protection, Crop Nutrition, and Emerging Solutions. The company was founded by Gastón Paladini, Henk Hoogenkamp, and Martin Salinas in 2020 and is headquartered in George Town, Cayman Islands.

Moolec Science SA

Moolec Science is currently the focus of heavy social media speculation and high volatility, with traders highlighting its extremely small float and high borrowing costs as catalysts for potential short-squeeze setups. The community remains deeply divided, balancing excitement over proprietary molecular farming breakthroughs against strong warnings regarding the stock's history of reverse splits and significant cash burn.

Our vision is to create a global exchange using Ethereum blockchain, where everyone on this planet has the opportunity to buy and sell mobile bandwidth in any country just like you buy foreign currencies on FOREX.

DENT

DENT is currently trending as community members speculate on potential price breakouts, with many sharing long-term price predictions and debating whether the asset is a sleeping giant or a stagnant project. Traders are actively discussing accumulation strategies, analyzing technical patterns, and monitoring volume spikes as they look for signs of a rally.

Rambus, Inc. engages in the provision of cutting-edge semiconductor and Internet Protocol products, spanning memory and interfaces to security, smart sensors and lighting. Its products include Memory Interface Chips, Interface IP, and Security IP. The company was founded by P. Michael Farmwald and Mark A. Horowitz in March 1990 and is headquartered in Sunnyvale, CA.

Rambus Inc.

Rambus is experiencing significant volatility and price swings following a mixed earnings report that missed earnings-per-share expectations despite a revenue beat. The community is actively debating the company's long-term potential as an AI-focused 'pick-and-shovel' play, with some investors viewing the post-earnings pullback as a prime accumulation opportunity while others warn of potential downside due to operational execution risks.

Rumble, Inc. engages in operating an online neutral video platform. It operates through the following geographical segments: United States, Canada, and Other. The company was founded in October 2013 by Chris Pavlovski and is headquartered in Longboat Key, FL.

Rumble Inc - Ordinary Shares - Class A

Rumble Inc

Rumble is trending as investors bet on a massive short squeeze driven by record-high short interest and a constrained share supply, bolstered by the strategic acquisition of Northern Data and heavy financial backing from Tether. Community discussions are heavily focused on the stock's potential as an AI-cloud infrastructure play and its strong ties to key political figures, with many users urging others to hold firm to force short sellers to cover.

Domino's Pizza, Inc. engages in the management of a network of company-owned and franchise-owned pizza stores. It operates through the following segments: U.S. Stores, International Franchise, and Supply Chain. The U.S. Stores segment consists primarily of franchise operations. The International Franchise segment comprises a network of franchised stores. The Supply Chain segment manages regional dough manufacturing and food supply chain centers. The company was founded by James Monaghan and Thomas Stephen Monaghan in 1960 and is headquartered in Ann Arbor, MI.

Dominos Pizza Inc

Domino's Pizza is trending as investors react to a recent earnings report that featured a mixed performance, highlighted by an earnings per share miss alongside a slight revenue beat. The community remains focused on the company's ability to drive sales through value-oriented promotions and digital delivery partnerships despite concerns over weak consumer sentiment and rising industry competition.

Celestica, Inc. engages in the provision of supply chain solutions globally to equipment manufacturers and service providers. It operates through the Advanced Technology Solutions (ATS) and Connectivity and Cloud Solutions (CCS) segments. The ATS segment includes aerospace and defense, industrial, smart energy, health tech, and capital equipment businesses. The CCS segment consists of enterprise communications, telecommunications, servers, and storage businesses. The company was founded in 1994 and is headquartered in Toronto, Canada.

Celestica, Inc. - Ordinary Shares (Subordinate Voting)

Celestica, Inc.

Celestica is currently in focus as investors digest a mix of strong quarterly earnings and raised guidance against the backdrop of an AI-driven infrastructure buildout. While the community is actively debating the stock's valuation, recent price volatility, and the impact of sector-wide competitive dynamics, sentiment remains sharply divided between those viewing the pullback as a buying opportunity and others concerned about speculative headwinds.

Joby Aviation, Inc. is a transportation company, which engages in developing an all-electric, vertical take-off and landing aircraft that intends to operate as a commercial passenger aircraft. The company was founded by Bevirt Joebenn in 2009 and is headquartered in Santa Cruz, CA.

Joby Aviation Inc

Joby Aviation is trending as the community highlights the recent completion of point-to-point electric air taxi demonstration flights in New York City, which serves as a major real-world proof point for urban air mobility. Investors are actively debating the company's transition from prototype testing to infrastructure integration, with sentiment split between those focused on long-term growth catalysts and those concerned by ongoing execution challenges and stock price volatility.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$SLS So many brand new id&#39;s here, just a PSA: Aza+VEN BAT - Best Available Treatment for Control Arm Patients recently failed 3 large phase 3 trials conducted by $ABBV  
Verona high Risk MDS/ AML precursor Failed 
VIALE-T Post Transplant Maintenance Failed 
VIALE-M AML First Remission Maintenance Trial Failed 
 
All While we are seeing Miraculous OS in AML Second Remission REGAL P3 Trial Patients - with at Least 47 / 127 remaining alive 25 months -  
DrJamy was asked - what is the longest Os you see in practice for Patients on BAT - He answers the question saying BAT Median is 6-8 months and  -- &quot;You will not see survival past 12 months&quot;  
 
at least 47 Patients Remain in the REGAL P3 at least 25 months since enrollment completed - 2+years OS minimum - ranging up to 63 months When enrollment began.

Anthony

Captain

5,500% ROI this quarter

Kris Kotsay

OnTheBalance

Green_Dream

Shultzy

GATA2016

Lion

Longnstrongdong

Mike Hayes

$SLS bumping around $5 per share, up to 8 back to $7 and was trading at $10 - the Day the P3 results announced $ABVX drug would be getting fda approval to generate billions in revenue. 
T1 Trading Halt 
+600% Gap UP to $60 Per Share  
And it Kept Climbing - to a high of $148  
 
$RVMD just added $15B in Market Value - in 2 days, based on its P3 Data, 13.6 MOS vs 7 pancreatic, 2l  
 
If you understand why you won&#39;t hesitate investing in SLS. 
 
When the Gps Regal Phase 3 Results are announced, the entire market will wish they were loading in sub $5 ... BR added in HIGHER.

StockTwits Web

SELLAS Life Sciences Group Inc

Abivax - ADR

Revolution Medicines Inc

$SLS $ABVX $RVMD The IDMC for the SLS Phase 3 Trial UNBLINDED Actual MOS and IR Data from the interim Analysis at 60 - events. 
- Since then the SLS MCap is up 1,000% 
- Industry Players Know Gps is the reason we are seeing miraculous all pooled Survival - 80% IR Rates in the ACTUAL ONGOING P3  
Ir is correlated w Survival for Gps Patients.  
 
Buy and HOLD - phase 3 results are coming.

Abbvie Inc

 So many brand new id's here, just a PSA: Aza+VEN BAT - Best Available Treatment for Control Arm Patients recently failed 3 large phase 3 trials conducted by 

  
Verona high Risk MDS/ AML precursor Failed 
VIALE-T Post Transplant Maintenance Failed 
VIALE-M AML First Remission Maintenance Trial Failed 
 
All While we are seeing Miraculous OS in AML Second Remission REGAL P3 Trial Patients - with at Least 47 / 127 remaining alive 25 months -  
DrJamy was asked - what is the longest Os you see in practice for Patients on BAT - He answers the question saying BAT Median is 6-8 months and  -- "You will not see survival past 12 months"  
 
at least 47 Patients Remain in the REGAL P3 at least 25 months since enrollment completed - 2+years OS minimum - ranging up to 63 months When enrollment began.